PortfoliosLab logo
HIMS vs. IESC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HIMS and IESC is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

HIMS vs. IESC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hims & Hers Health, Inc. (HIMS) and IES Holdings, Inc. (IESC). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

HIMS:

2.78

IESC:

0.52

Sortino Ratio

HIMS:

2.94

IESC:

1.25

Omega Ratio

HIMS:

1.39

IESC:

1.16

Calmar Ratio

HIMS:

5.08

IESC:

0.63

Martin Ratio

HIMS:

10.77

IESC:

1.71

Ulcer Index

HIMS:

29.79%

IESC:

25.50%

Daily Std Dev

HIMS:

110.09%

IESC:

73.00%

Max Drawdown

HIMS:

-87.29%

IESC:

-99.54%

Current Drawdown

HIMS:

-24.41%

IESC:

-39.49%

Fundamentals

Market Cap

HIMS:

$9.13B

IESC:

$4.77B

EPS

HIMS:

$0.53

IESC:

$11.96

PE Ratio

HIMS:

79.02

IESC:

19.92

PEG Ratio

HIMS:

3.85

IESC:

0.00

PS Ratio

HIMS:

6.18

IESC:

1.53

PB Ratio

HIMS:

19.15

IESC:

6.77

Total Revenue (TTM)

HIMS:

$1.78B

IESC:

$3.13B

Gross Profit (TTM)

HIMS:

$1.33B

IESC:

$768.07M

EBITDA (TTM)

HIMS:

$123.98M

IESC:

$368.76M

Returns By Period

In the year-to-date period, HIMS achieves a 114.89% return, which is significantly higher than IESC's 22.23% return.


HIMS

YTD

114.89%

1M

76.20%

6M

121.96%

1Y

302.17%

5Y*

39.21%

10Y*

N/A

IESC

YTD

22.23%

1M

29.51%

6M

-13.98%

1Y

37.85%

5Y*

62.03%

10Y*

41.06%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HIMS vs. IESC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIMS
The Risk-Adjusted Performance Rank of HIMS is 9696
Overall Rank
The Sharpe Ratio Rank of HIMS is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of HIMS is 9494
Sortino Ratio Rank
The Omega Ratio Rank of HIMS is 9393
Omega Ratio Rank
The Calmar Ratio Rank of HIMS is 9999
Calmar Ratio Rank
The Martin Ratio Rank of HIMS is 9595
Martin Ratio Rank

IESC
The Risk-Adjusted Performance Rank of IESC is 7272
Overall Rank
The Sharpe Ratio Rank of IESC is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of IESC is 7272
Sortino Ratio Rank
The Omega Ratio Rank of IESC is 7070
Omega Ratio Rank
The Calmar Ratio Rank of IESC is 7676
Calmar Ratio Rank
The Martin Ratio Rank of IESC is 7171
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HIMS vs. IESC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and IES Holdings, Inc. (IESC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current HIMS Sharpe Ratio is 2.78, which is higher than the IESC Sharpe Ratio of 0.52. The chart below compares the historical Sharpe Ratios of HIMS and IESC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

HIMS vs. IESC - Dividend Comparison

Neither HIMS nor IESC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HIMS vs. IESC - Drawdown Comparison

The maximum HIMS drawdown since its inception was -87.29%, smaller than the maximum IESC drawdown of -99.54%. Use the drawdown chart below to compare losses from any high point for HIMS and IESC. For additional features, visit the drawdowns tool.


Loading data...

Volatility

HIMS vs. IESC - Volatility Comparison


Loading data...

Financials

HIMS vs. IESC - Financials Comparison

This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and IES Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20212022202320242025
586.01M
833.96M
(HIMS) Total Revenue
(IESC) Total Revenue
Values in USD except per share items

HIMS vs. IESC - Profitability Comparison

The chart below illustrates the profitability comparison between Hims & Hers Health, Inc. and IES Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%20212022202320242025
73.5%
25.1%
(HIMS) Gross Margin
(IESC) Gross Margin
HIMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Hims & Hers Health, Inc. reported a gross profit of 430.69M and revenue of 586.01M. Therefore, the gross margin over that period was 73.5%.

IESC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, IES Holdings, Inc. reported a gross profit of 208.87M and revenue of 833.96M. Therefore, the gross margin over that period was 25.1%.

HIMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Hims & Hers Health, Inc. reported an operating income of 57.90M and revenue of 586.01M, resulting in an operating margin of 9.9%.

IESC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, IES Holdings, Inc. reported an operating income of 92.70M and revenue of 833.96M, resulting in an operating margin of 11.1%.

HIMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Hims & Hers Health, Inc. reported a net income of 49.49M and revenue of 586.01M, resulting in a net margin of 8.4%.

IESC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, IES Holdings, Inc. reported a net income of 70.65M and revenue of 833.96M, resulting in a net margin of 8.5%.